ARTICLE | Company News
CSL, MedImmune Inc. deal
November 13, 2006 8:00 AM UTC
CSL will acquire MEDI's CytoGam cytomegalovirus immune globulin to prevent cytomegalovirus (CMV) disease associated with transplantation. MEDI, which said CytoGam no longer fits into its core area of...